Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 526 (1) , 231-238
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (21772144)
- National Key Research & Development (R&D) Program of China (2017YFD0201400, 2017YFD0201403)
This publication has 42 references indexed in Scilit:
- Understanding the role of TDP-43 and FUS/TLS in ALS and beyondCurrent Opinion in Neurobiology, 2011
- TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathiesTrends in Molecular Medicine, 2011
- TDP-43 and FUS: a nuclear affairTrends in Neurosciences, 2011
- TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegenerationHuman Molecular Genetics, 2010
- Inflammation in neurodegenerative diseasesImmunology, 2010
- Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicityProceedings of the National Academy of Sciences, 2009
- Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 ProteinopathiesJournal of Biological Chemistry, 2009
- Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microgliaNeuropharmacology, 2004
- Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem CellsJournal of Cell Biology, 2001
- Toxicity of ALS-Linked SOD1 MutantsScience, 2000